US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 57.680
  • -0.320-0.55%
Close Dec 27 16:00 ET
  • 57.750
  • +0.070+0.12%
Post 20:01 ET
116.99BMarket Cap-16.11P/E (TTM)

About Bristol-Myers Squibb Company

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Company Profile

SymbolBMY
Company NameBristol-Myers Squibb
Listing DateJun 1, 1969
Issue Price40.50
Founded1933
CEODr. Christopher S. Boerner, PhD
MarketNYSE
Employees34100
Fiscal Year Ends12-31
AddressRoute 206 & Province Line Road
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08543
Phone1-609-252-4621

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Christopher S. Boerner, PhD
  • Chairman of the Board and Chief Executive Officer
  • 8.46M
  • David V. Elkins
  • Executive Vice President and Chief Financial Officer
  • 7.17M
  • Amanda Ahn Poole
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Adam Lenkowsky
  • Executive Vice President and Chief Commercialization Officer
  • --
  • Gregory Scott Meyers
  • Executive Vice President, Chief Digital Officer and Chief Technology Officer
  • --
  • Dr. Robert M. Plenge
  • Executive Vice President, Chief Research Officer and Head of Research
  • --
  • Dr. Samit Hirawat, M.D.
  • Executive Vice President, Chief Medical Officer and Head of Development
  • 6.23M
  • Cari Gallman
  • Executive Vice President, Corporate Affairs
  • --
  • Sandra Leung
  • Executive Vice President and General Counsel
  • 5.92M
  • Phil Holzer
  • Senior Vice President and Controller
  • --
  • Karin Shanahan
  • Executive Vice President, Global Product Development and Supply
  • --
  • Lynelle Hoch
  • President, Cell Therapy Organization
  • --
  • Dr. Julia A. Haller, M.D.
  • Independent Director
  • 371.68K
  • Phyllis R. Yale
  • Independent Director
  • 365.00K
  • Michael R. McMullen
  • Independent Director
  • --
  • Dr. Manuel Hidalgo Medina, M.D.,PhD
  • Independent Director
  • 335.00K
  • Peter J. Arduini
  • Independent Director
  • 359.68K
  • Derica W. Rice
  • Independent Director
  • 375.00K
  • Dr. Deepak L. Bhatt, M.D.,M.P.H.
  • Independent Director
  • 329.97K
  • Theodore R. Samuels
  • Lead Independent Director
  • 425.00K
  • Paula A. Price
  • Independent Director
  • 365.00K
  • Dr. Karen H. Vousden, PhD
  • Independent Director
  • 344.74K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.